Published in Arch Dermatol Res on April 07, 1978
A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med (1970) 15.86
Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G. Science (1968) 7.70
A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47
The human rosette-forming cell as a marker of a population of thymus-derived cells. J Clin Invest (1972) 4.80
Identification of two populations of immunoglobulin-bearing lymphocytes in man. J Immunol (1975) 3.83
Identification of three different human lymphocyte populations by surface markers. Transplant Rev (1973) 3.41
Studies of surface immunoglobulins on human B lymphocytes. I. Dissociation of cell-bound immunoglobulins with acid pH or at 37 degrees C. J Immunol (1975) 2.77
On the etiology of vitiligo and gray hair. Am J Med (1971) 1.88
Thymus-derived rosette-forming cells. N Engl J Med (1973) 1.50
[MELANIN ANTIBODIES IN VITILIGO]. Hautarzt (1965) 1.34
Membrane-associated immunoglobulin determinants on bone marrow and blood lymphocytes in the pediatric age group and on fetal tissues. Ann N Y Acad Sci (1975) 1.24
Autoimmune vitiligo: detection of antibodies to melanin-producing cells. N Engl J Med (1977) 1.17
Thymus-derived lymphocytes in the Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci (1977) 0.83
Chronic anal ulceration due to nicorandil. Br J Dermatol (2004) 3.18
Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol (1998) 2.20
Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet (1995) 1.90
Rab27a: A key to melanosome transport in human melanocytes. J Cell Biol (2001) 1.86
Television-viewing habits and sleep disturbance in school children. Pediatrics (1999) 1.77
The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. Br J Dermatol (2001) 1.75
Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J (2000) 1.73
Roaccutane treatment guidelines: results of an international survey. Dermatology (1997) 1.70
What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65
Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5). Nat Genet (1994) 1.63
Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol (1998) 1.62
Dominant dystrophic epidermolysis bullosa associated with pyloric stenosis and congenital absence of skin. Arch Dermatol (2001) 1.60
Giant oral aphthous ulcers induced by nicorandil. Br J Dermatol (1998) 1.58
Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product. J Cell Biol (1996) 1.57
Arthritis, collagenous colitis, and discoid lupus. Ann Intern Med (1994) 1.52
PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. J Invest Dermatol (1980) 1.46
Defective expression of plectin/HD1 in epidermolysis bullosa simplex with muscular dystrophy. J Clin Invest (1996) 1.45
EMLA cream as a topical anesthetic for the repeated mechanical debridement of venous leg ulcers: a double-blind, placebo-controlled study. J Am Acad Dermatol (1999) 1.41
[Extracutaneous manifestations of neutrophilic dermatosis]. Ann Dermatol Venereol (1996) 1.41
Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation. J Biol Chem (1998) 1.40
[Oral photochemotherapy in vitiligo (author's transl)]. Ann Dermatol Venereol (1979) 1.39
[Atypical clinical forms of bullous pemphigoid]. Ann Dermatol Venereol (1990) 1.39
Malignant lymphoma and dermatitis herpetiformis. Dermatology (1994) 1.39
Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol (2008) 1.39
Fibroblastic rheumatism: clinical, histological, immunohistological, ultrastructural and biochemical study of a case. Br J Dermatol (1993) 1.38
[Practical use of antiseptics in dermatology]. Ann Dermatol Venereol (1989) 1.38
Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10. J Biol Chem (2000) 1.36
Transposable B2 SINE elements can provide mobile RNA polymerase II promoters. Nat Genet (2001) 1.35
Monoclonal antibody GB3, a new probe for the study of human basement membranes and hemidesmosomes. Exp Cell Res (1987) 1.34
Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J Biol Chem (1995) 1.27
Inhibition of the phosphatidylinositol 3-kinase/p70(S6)-kinase pathway induces B16 melanoma cell differentiation. J Biol Chem (1996) 1.27
Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa. Lab Invest (1991) 1.23
Developmental expression of nicein adhesion protein (laminin-5) subunits suggests multiple morphogenic roles. Cell Adhes Commun (1994) 1.20
Congenital constriction band of the trunk. Pediatr Dermatol (1998) 1.19
The short arm of the laminin gamma2 chain plays a pivotal role in the incorporation of laminin 5 into the extracellular matrix and in cell adhesion. J Cell Biol (2001) 1.19
Ultraviolet B radiation acts through the nitric oxide and cGMP signal transduction pathway to stimulate melanogenesis in human melanocytes. J Biol Chem (1996) 1.18
Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol (2005) 1.18
The 100-kDa chain of nicein/kalinin is a laminin B2 chain variant. Eur J Biochem (1994) 1.17
A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa. Hum Mol Genet (1995) 1.17
Inhibition of Rho is required for cAMP-induced melanoma cell differentiation. Mol Biol Cell (1998) 1.15
PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes. Cell Death Differ (2004) 1.11
Diagnostic and neural analysis of skin cancer (DANAOS). A multicentre study for collection and computer-aided analysis of data from pigmented skin lesions using digital dermoscopy. Br J Dermatol (2003) 1.09
Further diseases manifesting a uniform vascular response to different aetiological factors. Histopathology (1985) 1.08
[Treatment of scleroderma]. Ann Med Interne (Paris) (1983) 1.07
Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia. Gene Ther (1998) 1.07
Lack of hypocomplementemia in chronic urticaria. Arch Dermatol (2000) 1.06
A study of nineteen immunocompromised patients with extensive skin lesions caused by Pseudomonas aeruginosa with and without bacteremia. Acta Derm Venereol (1991) 1.06
Aeromonas hydrophila with plasmid-borne class A extended-spectrum β-lactamase TEM-24 and three chromosomal class B, C, and D β-lactamases, isolated from a patient with necrotizing fasciitis. Antimicrob Agents Chemother (2004) 1.05
Cloning and complete primary structure of the mouse laminin alpha 3 chain. Distinct expression pattern of the laminin alpha 3A and alpha 3B chain isoforms. J Biol Chem (1995) 1.04
The majority of epidermal Merkel cells are non-proliferative: a quantitative immunofluorescence analysis. Acta Derm Venereol (1987) 1.03
The safety of hydroquinone. J Eur Acad Dermatol Venereol (2006) 1.02
A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol (2002) 1.01
Nitric oxide produced by ultraviolet-irradiated keratinocytes stimulates melanogenesis. J Clin Invest (1997) 1.01
Oral photochemotherapy in the treatment of lichen planus (LP). Clinical results, histological and ultrastructural observations. Br J Dermatol (1978) 1.00
[Scleroderma en coup de sabre with homolateral chronic glaucoma (author's transl)]. Ann Dermatol Venereol (1977) 1.00
Evaluation of cutaneous photodamage using a photographic scale. Br J Dermatol (1994) 1.00
An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes. Br J Dermatol (2013) 0.99
Psoriasis: an epidemiological evaluation of disease burden in 590 patients. J Eur Acad Dermatol Venereol (2010) 0.99
PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study. Br J Dermatol (1979) 0.99
Treatment of erosive oral lichen planus by the 308 nm excimer laser. Lasers Surg Med (2004) 0.99
Anatomical mapping of Merkel cells in normal human adult epidermis. Br J Dermatol (1991) 0.98
Acral hyperpigmented macules and longitudinal melanonychia in AIDS patients. Br J Dermatol (1992) 0.98
Cutaneous leukocytoclastic vasculitis and renal cancer: two cases. Am J Med (1993) 0.98
Morphological, immunological and immunocytochemical identification of lymphocytes extracted from cutaneous infiltrates. Clin Exp Immunol (1976) 0.97
Ofuji papuloerythroderma: a new European case. Dermatology (1993) 0.97
TFE3, a transcription factor homologous to microphthalmia, is a potential transcriptional activator of tyrosinase and TyrpI genes. Mol Endocrinol (2000) 0.97
Normal and psoriatic human skin grafts on "nude" mice: morphological and immunochemical studies. J Invest Dermatol (1981) 0.97
Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial. Br J Dermatol (2007) 0.96
Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad Dermatol (1992) 0.96
Identification of a 37 kilodalton protein at the epidermal basement membrane by an antiserum to human amnion. J Invest Dermatol (1986) 0.96
GB3 monoclonal antibody for diagnosis of junctional epidermolysis bullosa. Lancet (1986) 0.96
Involvement of microphthalmia in the inhibition of melanocyte lineage differentiation and of melanogenesis by agouti signal protein. J Biol Chem (1998) 0.95
GB3 monoclonal antibody for the diagnosis of junctional epidermolysis bullosa: results of a multicenter study. J Am Acad Dermatol (1990) 0.95
Murine laminin alpha3A and alpha3B isoform chains are generated by usage of two promoters and alternative splicing. J Biol Chem (1997) 0.95
A homozygous nonsense mutation in the PLEC1 gene in patients with epidermolysis bullosa simplex with muscular dystrophy. J Clin Invest (1996) 0.95
Functional Re-expression of laminin-5 in laminin-gamma2-deficient human keratinocytes modifies cell morphology, motility, and adhesion. J Biol Chem (1996) 0.94
Pseudomonas aeruginosa O-11 folliculitis. Development into ecthyma gangrenosum in immunosuppressed patients. Arch Dermatol (1985) 0.94
Treatment of vitiligo by 308-nm excimer laser: an evaluation of variables affecting treatment response. Lasers Surg Med (2004) 0.94
Three activator protein-1-binding sites bound by the Fra-2.JunD complex cooperate for the regulation of murine laminin alpha3A (lama3A) promoter activity by transforming growth factor-beta. J Biol Chem (1998) 0.94
Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy. J Eur Acad Dermatol Venereol (2012) 0.94
Repeated UVB irradiations do not have the same potential to promote stimulation of melanogenesis in cultured normal human melanocytes. J Cell Sci (1993) 0.94
Cloning of the laminin alpha 3 chain gene (LAMA3) and identification of a homozygous deletion in a patient with Herlitz junctional epidermolysis bullosa. Genomics (1995) 0.93
Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial. Br J Dermatol (2015) 0.92
Ecthyma gangrenosum caused by Klebsiella pneumoniae. Int J Dermatol (1995) 0.92
Divided nevus of the penis: an unusual location. Arch Dermatol (1998) 0.92
Anatomic distribution of melanocytes in normal nail unit: an immunohistochemical investigation. Am J Dermatopathol (1997) 0.92
Rapid prenatal diagnosis of epidermolysis bullosa letalis using GB3 monoclonal antibody. Br J Dermatol (1987) 0.92
Involvement of FKHRL1 in melanoma cell survival and death. Pigment Cell Melanoma Res (2008) 0.91
The tyrosinases of normal and diseased human skin (naevi, malignant melanoma, vitiligo). Arch Dermatol Res (1975) 0.91
Episodic erythema gyratum repens with ichthyosis and palmoplantar hyperkeratosis without signs of internal malignancy. Clin Exp Dermatol (1989) 0.91
[Cheilitis granulomatosa in a child]. Arch Pediatr (2000) 0.91
Melasma in Latin America: options for therapy and treatment algorithm. J Eur Acad Dermatol Venereol (2009) 0.91
Juvenile pityriasis rubra pilaris associated with hypogammaglobulinaemia and furunculosis. Br J Dermatol (1994) 0.91
Impairement of thymus derived rosette forming cells during photochemotherapy (psoralen--U.V.A.). Arch Dermatol Res (1978) 0.90
The basement membrane protein BM-600/nicein codistributes with kalinin and the integrin alpha 6 beta 4 in human cultured keratinocytes. Exp Cell Res (1993) 0.90
Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients. Exp Dermatol (1992) 0.90
Milia during treatment of mycosis fungoides: follicular mycosis fungoides? Acta Derm Venereol (1994) 0.90
Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial. Br J Dermatol (2001) 0.89